Amytrx Therapeutics is a drug development company with patented cell penetrating peptides providing a transforming approach to treating inflammation, the cause of hundreds of debilitating diseases. These peptides have successfully undergone extensive testing in animal models of human inflammation and metabolic syndrome as proof of therapeutic concepts and are in pre-clinical animal safety studies needed to file an IND to initiate human trials.